Federation des caisses Desjardins du Quebec’s Mangoceuticals MGRX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio MGRX Stock Details MGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,100	Closed	-$13.8K	–	2797
2025 Q1	$13.8K	Buy	7,100 +2,500	+54%	+$8.99K	﹤0.01%	1849
2024 Q4	$11.1K	Buy	+4,600	New	+$12.1K	﹤0.01%	1846
2024 Q2	–	Sell	-1,467	Closed	-$4.77K	–	2539
2024 Q1	$4.77K	Hold	1,467	–	–	﹤0.01%	1968
2023 Q4	$6.09K	Buy	+1,467	New	+$13K	﹤0.01%	1862

Other funds holding MGRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's MGRX Position: Q2 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Mangoceuticals (MGRX) in Q2 2025, closing a stake of 7,100 shares — an estimated $13.8K sold.

Federation des caisses Desjardins du Quebec first reported a position in MGRX in Q4 2023 and held it in 4 quarters. The position peaked at $13.8K in Q1 2025. 10 funds tracked by Wall St. Rank hold MGRX as of Q2 2025.

Federation des caisses Desjardins du Quebec reported no remaining Mangoceuticals position as of Q2 2025 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 7,100 Mangoceuticals shares in Q2 2025, an estimated $13.8K.
Federation des caisses Desjardins du Quebec first reported a position in Mangoceuticals in Q4 2023 and held it in 4 quarters.
Federation des caisses Desjardins du Quebec's Mangoceuticals position peaked at $13.8K in Q1 2025.
10 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2025, filed 14 Aug 2025.